Chinagene Tech is an ophthalmology clinical genetic diagnosis organization
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 30, 2022 | Series A | ¥100M | 1 | Longqian Capital | — | Detail |
Mar 29, 2021 | Seed | ¥70M | 2 | Lotus Lake Ventures | — | Detail |
Mar 6, 2019 | Corporate Round | ¥10M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Longqian Capital | Yes | Series A |
Lotus Lake Ventures | Yes | Seed |
Longmen Capital | — | Seed |
Beijing Shoukai Kaiyang Venture Capital Center | — | Corporate Round |